NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm today announced that it has commenced an investigation into allegations that AspenBio Pharma, Inc. (“AspenBio” or the “Company”) (Nasdaq: APPY - News) violated the federal securities laws by issuing false and misleading statements to investors about its product candidate AppyScore. Since as early February 15, 2006, AspenBio has been touting AppyScore ...

Hagens Berman Sobol Shapiro LLP announced it filed a class-action lawsuit today against Charles Schwab & Co. on behalf of investors who owned shares in the Schwab Total Bond Market Fund as of Nov. 30, 2006.

Hagens Berman Sobol Shapiro LLP announced it filed a class-action lawsuit today against Charles Schwab & Co. on behalf of investors who owned shares in the Schwab Total Bond Market Fund as of Nov. 30, 2006.

Hagens Berman Sobol Shapiro LLP announced it filed a class-action lawsuit today against Charles Schwab & Co. on behalf of investors who owned shares in the Schwab Total Bond Market Fund as of Nov. 30, 2006.

NEW YORK -- Pomerantz Haudek Grossman & Gross LLP reminds investors that a class action lawsuit was filed in the United States District Court, Western District of Kentucky against Almost Family, Inc. and certain of its top officials.

It was a cautious day's trade ahead of employment figures out in the US tonight, but the chance of increased poker machine regulation and various shareholder legal actions drove some stocks lower.

[ABC] - It was a cautious day s trade ahead of employment figures out in the US tonight, but the chance of increased poker machine regulation and various shareholder legal actions drove some stocks lower.Aristocrat ...

Fortescue Metals Group Ltd. , Australia’s third-biggest iron-ore producer, said shareholder Leucadia National Corp . is seeking to have courts rewrite terms of its investment agreement to thwart Fortescue from issuing additional securities.

Sigma Pharmaceuticals expects to be hit with a shareholder class action lawsuit over its alleged failure to disclose its financial position before a capital raising in September 2009.

Sigma Pharmaceuticals expects to be hit with a shareholder class action lawsuit over its alleged failure to disclose its financial position before a capital raising in September 2009.